Company: ACHV
Filing Date: 2025-06-27
Form Type: 8-K
Source: 0000950170-25-091055
Chunk: 0

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-06-27
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01

Other Events.

On June 26, 2025, Achieve issued a press release announcing that it had commenced the Offering. On June 26, 2025, Achieve issued a press release announcing that it had priced the Offering. Copies of these press releases are attached as Exhibits 99.1 and 99.2 hereto, respectively, and the information contained therein is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                  
          1.1      Underwriting Agreement, dated June 26, 2025                                  
 ────────────────────────────────────────────────────────────────────────────────────────────────
          4.1      Form of Warrant                                                              
          5.1      Opinion of Fenwick & West LLP                                                
         23.1      Consent of Fenwick & West LLP (included in Exhibit 5.1)                      
         99.1      Press Release, dated June 26, 2025                                           
         99.2      Press Release, dated June 26, 2025                                           
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

________________________

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of the U. S. Private Securities Litigation Reform Act of 1995 and other federal securities laws. Any statements contained herein that do not describe historical facts, including, but not limited to, statements regarding the expected closing date, net proceeds of the Offering and the anticipated use of proceeds of the Offering, are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward-looking statements. Such risks and uncertainties include, among others, the risks identified in Achieve’s filings with the SEC, including its Quarterly Report on Form 10-Q for the three months ended March 31, 2025, filed with the SEC on May 13, 2025, the prospectus supplement related to the Offering, and subsequent filings with the SEC. Any of these risks and uncertainties could materially and adversely affect Achieve’s results of operations, which would, in turn, have a significant and adverse impact on Achieve’s stock price. Achieve cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. Achieve undertakes no obligation